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Purpose: Retinitis pigmentosa 1 (RP1) is a major gene responsible for both autosomal dominant and autosomal recessive
retinitis pigmentosa (RP). We have previously identified three disease-causing mutations out of 174 RP patients. In this
study, we investigated a new cohort of Chinese RP patients to further evaluate the contribution of RP1 mutations to cause
RP.
Methods: A group of 55 nonsyndromic RP patients, the majority of them isolated cases or without information on family
history, were screened for mutations in the entire coding sequences of RP1, using direct DNA sequencing. All detected
variants were genotyped in 190 controls, while the three putative mutations were additionally genotyped in 362 controls
subjects. Web-based programs, including PolyPhen, Sorting Intolerant from Tolerant (SIFT), Prediction of Pathological
Mutations  (PMUT),  Single  Amino  Acid  Polymorphism  Disease-Association  Predictor  (SAP),  ScanProsite,  and
ClustalW2, were used to predict the potential functional and structural impacts of the missense variants on RP1.
Results: A total of 14 sequence changes were identified. Among them, five were novel and found only in the RP patients.
Two missense variants (p.K1370E and p.R1652L), which are conserved in primates, were predicted to have functional
and structural impacts on the RP1 protein. The other three variants (c.787+34T>C, p.I408L and p.L2015L) were considered
benign.
Conclusions: If these two novel missense variants are in fact pathogenic, then RP1 mutations account for approximately
2.18% (5/229) of RP cases in our Chinese cohort; this is similar to other ethnic groups. However, a relatively higher
frequency of missense mutations found in the Chinese patients may suggest an ethnic diversity in the RP1 mutation
patterns.
Retinitis  pigmentosa  (RP;  OMIM  268000;  Mendelian
Inheritance  in  Man;  National  Center  for  Biotechnology
Information, Bethesda, MD) refers to a heterogeneous group
of  inherited  retinal  dystrophies  characterized  by  night
blindness  and  progressive  loss  of  visual  field  due  to  the
degeneration of rod photoreceptors in the retina. In the late
stage,  the  central  vision  will  be  affected,  resulting  in
irreversible  blindness  [1].  Prevalence  of  RP  is  between
1/4,000 [2-5] and 1/6,000 [6] in western countries. Among
Chinese, the prevalence was 1/3,784 in a dispersed region of
China [7]. In the Peking eye study, the estimated prevalence
was as high as 1/1,000 among people aged over 40 in northern
China [8].
RP can present as autosomal recessive (arRP, 10%–45%),
autosomal dominant (adRP, 10%–30%), or X-linked (xlRP,
0%–15%). Around 35%–50% of RP cases have been denoted
as simplex RP (sRP) because of the absence of known family
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history of RP or segregation pattern [2,3,5,6,9-11]. More than
40 genes have been identified to cause RP, of which 20, 26,
and two genes were responsible for adRP, arRP, and xlRP,
respectively  (RetNet,  the  Retinal  Information  Network,
provided in the public domain by the University of Texas
Houston  Health  Science  Center,  Houston,  TX,  accessed
March 7, 2010). The RP1 locus was mapped by linkage testing
in a large adRP family in southeastern Kentucky [12,13]. The
gene  subsequently  linked  to  adRP  was  named  retinitis
pigmentosa  1  (RP1,  OMIM  603937)  [13].  Later  studies
revealed that mutations in RP1 cause both dominant [14-17]
and recessive forms of RP [18,19]. Most RP1 mutations are
single nucleotide substitutions that produce a premature stop
codon or insertion/deletion changes, resulting in a truncated
protein in Caucasian populations [20]. These mutations were
predicted to truncate the RP1 protein by approximately 50%
to 70% of the full length. Only a few missense variants, such
as  p.T373I  [18],  p.K663N  [16],  p.A669T  [18],  p.D984G
[21],  and  p.L1808P  [16],  have  been  found  to  be  disease
causing. RP1 is expressed prominently, if not only, in the
photoreceptor cells of the retina [15,19,22,23] and is involved
in the correct orientation and higher order stacking of outer
segment discs [24]. RP1 is a microtubule-associated protein
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1353forming part of the photoreceptor axoneme [25] and thus plays
an important role in photoreceptor function.
We previously evaluated the mutation profiles of RP1 in
Chinese RP patients by studying unrelated RP patients with
mixed phenotypes. We found that RP1 mutations (p.R677X
and p.D984G) accounted for about 1.2% of overall RP [21,
26,27], apparently lower than that in other populations [1,
28]. Recently, we identified two truncation mutations causing
arRP in a Chinese family [29]. In this study, we screened for
additional RP patients and control subjects to complement the
mutation profile of RP1 in Chinese patients.
METHODS
Study subjects: All study subjects recruited were of Chinese
ethnicity  and  were  given  complete  ocular  examinations,
including slit-lamp biomicroscopy, electroretinography, and
fundus  photography.  Diagnosis  of  nonsyndromic  RP  was
based on ophthalmic investigations and absence of systemic
signs associated with syndromic RP. Subjects were confirmed
to be free of any other major eye diseases, except mild senile
cataract in some elderly subjects. In total, 55 unrelated RP
patients were recruited, including 32 females and 23 males,
with ages ranging from 19 to 84 years. Inheritance patterns of
the disease were defined according to the family history of the
subjects. In some cases, however, there was no information
about  the  family  structure  for  heredity  classification.  The
control subjects were all unrelated, older than 60 years, and
had no family history of RP from which 190 of them (53 males
and  137  females)  were  from  Hong  Kong  and  had  been
described in our previous studies [26,27]. We also added
another 362 controls for validation of the putative mutations:
35 subjects from Hong Kong (11 males and 24 females, age
range 70 to 90 years), 180 from Beijing in northern China
[30] (88 males and 92 females, age range 60 to 89 years), and
147  from  Shantou  in  southern  China  (53  males  and  94
females, age range 63 to 96 years). All controls received
routine follow-up and complete ophthalmic examination to
ensure  that  they  remained  free  of  RP  or  other  major  eye
diseases  except  mild  senile  cataract.  Written  informed
consents  were  obtained  from  all  study  subjects  after
explanation of the nature of the study. All procedures were
conducted in accordance with the tenets of the Declaration of
Helsinki.  The  study  protocol  was  approved  by  the  Ethics
Committee on Human Research, the Chinese University of
Hong Kong and the respective review board on human subject
research at each participating academic institution. Peripheral
venous whole blood, 5 ml, was collected from each patient in
EDTA tubes and stored at −80 °C before genetic analysis.
Mutational screening of the RP1 gene in cases and controls:
Genomic  DNA  was  extracted  from  whole  blood  using  a
commercial kit (QIAamp DNA Blood kit; Qiagen, Valencia,
CA), according to the manufacturer’s instructions. In brief the
frozen whole blood samples were thawed and blood cells
lysed in QIAGEN Protease and Buffer AL in the kit. The DNA
was  obtained  by  precipitation.  Twenty-six  amplicons
covering  all  three  coding  exons  and  the  exon–intron
boundaries of RP1, as previously described [21,26], were
amplified in all patients and the 190 Hong Kong controls by
PCR and analyzed by direct DNA sequencing using dye-
termination  chemistry  (Big-Dye  Terminator  Cycle
Sequencing Reaction Kit; ver. 3.1; Applied Biosystems, Inc.,
Foster City, CA) on a DNA sequencer (3130XL; Applied
Biosystems), according to the supplier’s protocol. The DNA
sequences  were  compared  with  the  human  RP1
(ENSG00000104237) sequence in the Ensembl database. Any
rare variants detected were double confirmed by bidirectional
sequencing.  The  novel  putative  mutations  were  further
genotyped in the additional 362 control subjects.
Analysis of variants: We defined a variant as “novel” if it had
not been reported in the literature or registered in the Single
Nucleotide Polymorphism (SNP) database (provided in the
public  domain  by  the  National  Center  for  Biotechnology
Information,  Bethesda,  MD).  A  variant  was  regarded  as
potentially disease causing if it was (1) expected to alter the
amino acid sequence of the protein, (2) exclusively observed
in patients with RP, while completely absent from the control
subjects, and (3) predicted to alter the protein structure or
function through in silico analysis.
For the common RP1 sequence variants with minor allele
frequency  >5%  detected  in  both  patients  and  controls,
genotype frequencies were compared between the two groups
in a dominant genetic model using the χ2 test in SPSS (ver.
15.0; SPSS Inc., Chicago, IL). A Bonferroni method was used
to correct the p values in multiple comparisons. For the rare
missense variants detected exclusively in the RP patients, we
used four web-based programs to evaluate possible biologic
effects of the amino acid substitution on the structure and
function  of  the  RP1  protein,  including  (1)  Polymorphism
Phenotyping (PolyPhen provided by the Bork Group and the
Sunyaev  Lab,  Brigham  and  Women’s  Hospital,  Harvard
Medical School, Boston, MA), (2) Sorting Intolerant from
Tolerant (SIFT, provided in the public domain by the J. Craig
Venter  Institute,  Rockville,  MD),  (3)  Prediction  of
Pathological Mutations (PMUT, provided by the Molecular
Recognition and Bioinformatics Group, Institute for Research
in Biomedicine-Barcelona Science Park and University of
Barcelona, Barcelona, Spain), and (4) the Single Amino Acid
Polymorphism Disease-Association Predictor (SAP disease-
association predictor, provided by the Sapred Team, Center
for  Bioinformatics,  Peking  University,  Beijing,  China).
Possible alterations of protein motifs and functional sites were
assessed  by  scanning  through  the  PROSITE  database
(ScanProsite,  provided  by  the  Swiss-Prot  group,  Swiss
Institute  of  Bioinformatics,  Lausanne,  Switzerland).  We
further examined evolutionary conservation of the amino acid
residues in these variants by multiple sequence alignment
using  the  ClustalW2  program  (provided  by  the  European
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Institute, Cambridge, UK).
RESULTS
Classification of the retinitis pigmentosa cases: Based on
family  information,  the  55  nonsyndromic  RP  patients
presented with mixed inheritance patterns, with five (9.09%)
being classified as adRP, five (9.09%) as arRP, two (3.6%) as
xlRP, and 23 (41.8%) as sRP. The remaining 20 patients had
an unknown inheritance pattern due to the lack of familial
data.
Sequence variants detected in the RP1 gene and pathogenicity
assessment: A total of 14 RP1 variants were identified (Table
1).  Among  them,  six  (p.R872H,  p.N985Y,  p.A1670T,
p.S1691P, p.Q1725Q, and p.C2033Y) were common SNPs
registered in the SNP database. These six SNPs were found at
high  frequencies  among  the  control  subjects.  Association
analyses  showed  that  none  of  them  was  significantly
associated  with  RP  (pcorr>0.05).  Therefore,  they  were  not
considered disease-causing mutations.
We also identified eight rare variants, three of which
(p.G706R, p.Q1008Q, and c.6542C>T) occurred in both the
case and control subjects. The remaining five were novel and
not detected in the 552 control subjects from different areas
of China. Two of them (p.L2015L and intronic c.787+34T>C)
did  not  lead  to  amino  acid  change,  while  the  other  three
(p.I408L, p.K1370E, and p.R1652L) were missense changes.
The  impact  of  variant  p.I408L  was  predicted  to  be
“Borderline”  by  PolyPhen,  “Tolerated”  by  SIFT,  and
“Neutral” by PMUT, with a maximum reliability index of 9
(Table  2).  The  Grantham  score  was  5.  Based  on  these
assessments, p.I408L is less likely to be a disease-causing
mutation. The variant p.K1370E was predicted as “Potentially
damaging”  and  “Potentially  Intolerant”  by  PolyPhen  and
SIFT, respectively. Although predicted to be “Pathological”
by PMUT (reliability index of 0). The Grantham score for this
substitution  was  56,  being  moderately  conservative.
Therefore, p.K1370E is potentially disease causing. For the
p.R1652L variant, the predictions were “Possibly damaging”
by  PolyPhen,  “Potentially  Intolerant”  by  SIFT,  and
“Pathological”  (reliability  index  of  7)  by  PMUT.  With  a
Grantham  score  of  102,  p.R1652L  should  be  moderately
radical  and  highly  likely  to  be  a  functional  mutation.
PROSITE scanning showed that no structural or functional
domain was present at or around these two residues. However,
the variant p.R1652L was predicted to abolish one possible
protein kinase C phosphorylation site on the RP1 protein
(Table 3). Determination of the evolutionary conservation of
p.K1370E and p.R1652L by multiple amino acid sequence
alignment  of  the  human  RP1  with  the  protein  sequences
derived from chimpanzee, rhesus monkey, dog, horse, murine,
and cattle showed that both residues 1370 and 1652 in RP1
were conserved among the primates (Figure 1).
DISCUSSION
In the present study, we sequenced the RP1 gene in 55 newly
recruited  Chinese  RP  patients  and  identified  five  novel
variants,  providing  new  information  about  the  variation
pattern  of  the  gene.  Of  the  five  variants,  three  missense
variants were exclusively found in RP patients and absent in
the  552  control  subjects.  Therefore,  they  are  considered
excellent  candidate  disease-causing  mutations.
Unfortunately, as the family members of these three patients
did not provide consent to join our study, we were not able to
perform segregation analysis for the putative mutations. We
therefore used in silico analysis to provide some insights into
TABLE 1. SEQUENCE VARIANTS DETECTED IN THE RP1 GENE AMONG 55 CHINESE RP PATIENTS.
        Variation frequency +





Intron 3 c.787+34T>C / Novel 20090 0/190
Exon 4 c.1222A>C p.I408L Novel 20090 0/190
Exon 4 c.2116G>C * p.G706R [26] 20121 1/190
Exon 4 c.2615G>A p.R872H rs444772 43/55 130/190
Exon 4 c.2953A>T p.N985Y rs2293869 20149 27/190
Exon 4 c.3024G>A p.Q1008Q [26] 20090 1/190
Exon 4 c.4108A>G p.K1370E Novel 20090 0/190
Exon 4 c.4955G>T p.R1652L Novel 20090 0/190
Exon 4 c.5008G>A p.A1670T rs446227 44/55 106/190
Exon 4 c.5071T>C p.S1691P rs414352 44/55 106/190
Exon 4 c.5175A>G p.Q1725Q rs441800 44/55 106/190
Exon 4 c.6045A>G p.L2015L Novel 20090 0/190
Exon 4 c.6098G>A p.C2033Y rs61739567 20149 27/190
Exon 4 (3′UTR) c.6542C>T / [26] 20149 2/190
*One  patient was homozygous for the p.G706R variant while the other was heterozygous for the variant; +The variation
frequency was presented in a format of “variant genotypes/total genotypic counts”; / indicates “not applicable.”
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Descriptiontheir impacts. The three programs, i.e., PolyPhen, SIFT, and
the Grantham score, are frequently used algorithms in the
prediction  of  the  functionality  of  missense  SNPs  [31,32].
However, their predictions may sometimes be inconsistent,
although strong concordances have been observed [33]. We
therefore applied the PMUT program to provide additional
assessment.  By  using  these  tools  we  would  expect  that
p.I408L is less likely to be a functional mutation (Table 2),
although a segregation study would be of great interest to
confirm its role. This variant occurred in a patient with adRP.
Ocular  and  electroretinography  examinations  revealed  a
typical sign of RP (data not shown). By mutational analyses
of rhodopsin (RHO, OMIM 180380), photoreceptor-specific
nuclear receptor (NR2E3, OMIM 604485), and neural retina
leucine zipper (NRL, OMIM 162080) [29], we did not find
any variants in this subject (data not shown). Therefore, the





Location change change Type Sex Age
PSIC
score Prediction Score Prediction RI Score
Exon 4 c.1222A>C p.I408L adRP F 56 0/552 Borderline 1.234 Tolerant 0.29 Neutral 9 5




0.09 Pathological 0 56




0.1 Pathological 7 102
Type: Type of RP; PSIC: Position-Specific Independent Counts, a scoring system used in PolyPhen; RI: Reliability Index.
TABLE 3. PROTEIN DOMAIN AND POST-TRANSLATIONAL MODIFICATION SITE PREDICTIONS FOR THE RP1 WILD TYPE PROTEIN AND THE MISSENSE VARIANTS,
P.K1370E AND P.R1652L, WERE ANALYZED BY WEB-BASED ANALYSIS PROGRAM SCANPROSITE.
A. Description Wild type p.K1370E
Structural or functional domains Nil Nil
Post-translational modification site Nil Nil
B. Description Wild type p.R1652L
Structural or functional domains Nil Nil
Post-translational modification site    
Residue 1650–1652 PKC-phospho site (StR) Nil
Residue 1651–1653 PKC-phospho site (TrK) PKC-phospho site (TIK)
Difference between wild type and the p.K1370E variant, at position around residue 1370. B. Difference between wild type and
the p.R1652L variant, at position around residue 1652. Nil represents None of the protein domain or post-translational
modification site was predicted in related location . *PKC-phospho site: Protein kinase C phophosphorylation site. The prediction
is based on the amino acid sequence pattern of a serine (S) or threonine (T) residue found close to a C-terminal basic residue
such as arginine (R) or Lysine (K) [37,38].
Figure  1.  Multiple  protein  sequence
alignment  of  retinitis  pigmentosa  1
(RP1; partially), showing the location of
p.K1370E  and  p.R1652L.  The  two
residues  are  not  conserved  across
different  species.  The  accession
numbers of the RP1 protein sequences
of  different  species  are  as  follows:
Human  NP_006260.1,  chimpanzee
(Pan troglodytes) XP_528138.2, rhesus
monkey  (Macaca  mulatta)
XP_001083644.1,  dog  (Canis  lupus)
NP_001003040.1,  horse  (Equus
caballus)  XP_001498071.2,  murine
(Mus  musculus)  NP_035413.1,  and
cattle (Bos taurus) NP_776383.1
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Control PredictionadRP in this patient is likely to be caused by another yet-to-
be-identified mutation. In contrast, the variant p.R1652L was
likely  to  be  a  deleterious  substitution  with  consistent
predictions by PolyPhen,SIFT,PMUT, and Grantham score.
Variant p.K1370E was also predicted to be deleterious by the
four programs, although with a lower reliability index (Table
2). Meanwhile p.R1652 and p.K1370 were conserved among
primates (Figure 1). They are located in the region of the RP1
polypeptide  where  many  mutations  occur.  Furthermore,
p.R1652L was predicted to abolish one possible protein kinase
C  phosphorylation  site  on  the  protein  (Table  3).  Protein
phosphorylation  is  an  important  posttranslational
modification process that can alter the conformation and thus
function and localization of the protein [34]. The predicted
abolishment of the phosphorylation site can affect the normal
functioning of RP1. As a whole, our results are consistent for
pathologic  roles  of  p.R1652L  and  p.K1370E  in  RP.  The
patients with these postulated mutations had typical clinical
presentations  of  RP  (Figure  2),  although  the  clinical
presentations appear less severe than the truncation mutation
carrier [29]. Notably, the p.R1652L and p.K1370E carriers
were classified as sRP because their parents did not have the
disease. Thus, these two variants could be de novo mutations
causing adRP or could cause arRP in a digenic pattern co-
dominantly with another yet-to-identify mutation, which is
worth further investigation.
In our previous studies, we identified two RP1 mutations,
p.R677X and p.D984G, in two out of 173 Hong Kong Chinese
RP patients [21,26]. Recently we identified two truncation
mutations (c.5_6delGT and c.4941_4942insT) causing arRP
in a Chinese pedigree [29]. Combining these findings with the
two missense mutations detected in the current study, the total
contribution  of  RP1  mutations  is  approximately  2.18%
(5/229, 95% confidence interval 0.93%–5.0%) in our Chinese
cohort. So far, studies evaluating the RP1 in other Chinese RP
cohorts are limited. Recently, Sheng et al. [30] identified the
p.N985Y variant as the disease-causing mutation for adRP,
being  co-segregated  with  the  disease  in  the  pedigree  and
absent in 105 controls. Interestingly, the p.N985Y variant was
found to be very common in our study cohort, presenting in
14.2% (27/190) of control subjects. We do not know whether
the pedigree is of Han Chinese ethnicity due to the lack of data
in the Sheng et al. [30] report. We would expect, however,
that ethnic diversity of the RP1 mutation pattern also exists
within Chinese populations. In the study of Sheng et al., [30]
another  three  missense  variants  (p.P63I,  p.G79E,  and
p.P903L) were also found to occur at high frequencies and
exclusively  in  the  patient  group,  although  the  disease-
causative properties remained inconclusive [30]. In contrast,
no truncation mutation was found in their cohort. In light of
their  findings  and  ours,  missense  RP1  mutations  may  be
playing a prominent role in the genetic epidemiology of RP
in  Chinese  populations.  Further  studies  in  other  Chinese
cohorts with a larger sample size are warranted to confirm this.
To date, at least 41 RP1 mutations that are causative for
RP  have  been  reported,  most  of  which  are  truncation
Figure 2. Typical RP clinical presentations of the two putative missense mutation (p.K1370E and p.R1652L) carriers. They both appear to be
less severe than the truncation mutation carrier reported previously [29]. A: Electroretinogram (ERG) and automated visual field reports of
the p.K1370E carrier. B: Fundus photographs and automated visual field reports of the p.R1652L carrier, showing much milder clinical
manifestation in comparison to the carrier with p.S2RfxX16 and p.P1648SfsX13 truncation mutations [29]. Abbreviations: OD represents
Right eye; OS represents Left eye.
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missense mutations occur in Chinese RP patients (Table 4),
while only three out of 33 (9%) known truncations have been
identified in all the published Chinese RP1 mutations (Figure
3).  In  contrast,  most  known  truncation  mutations  were
detected  in  other  populations,  with  the  most  frequent
mutation, p.R677X, presenting in approximately 3% of adRP
patients in the United States [15]; it has also presented at
relatively high frequencies in the UK [20] and Italian [35]
populations.  Hence,  there  are  distinctly  differential  RP1
mutation patterns existing, if not globally, at least between the
Chinese and Caucasian populations.
So  far,  most  confirmed  pathologic  mutations  in  RP1
among  different  populations  are  nonsense  or  frameshift
mutations located in exon 4. These mutant transcripts are
predicted to be insensitive to the nonsense-mediated decay
pathway,  leading  to  the  production  of  truncated  proteins
lacking one-half to two-thirds of the C-terminal portion [36].
As it has been suggested that haploinsufficiency of RP1 is not
causative for RP [29], these truncated proteins may exert their
role in the pathogenesis of RP through a dominant negative
effect. Likewise, the missense mutations may also play a role
in RP etiology through a similar mechanism, which has yet to
be elucidated by functional assays.
In  summary,  we  have  identified  two  novel  missense
mutations (p.R1652L and p.K1370E). These mutations were
predicted to have functional impacts on RP1 and are likely to
be  pathogenic.  In  light  of  these  findings  along  with  the
findings of our previous studies, both RP1 truncation and
missense mutations may contribute to the etiology of RP,
accounting  for  approximately  2.18%  of  RP  cases  in  our
Chinese cohort, similar to other populations. Nevertheless, the
Chinese population has a disproportionally high frequency of
missense mutations, providing further insights into the ethnic
diversity of the genetic epidemiology of RP.
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TABLE 4. SUMMARY OF RP1 MISSENSE MUTATIONS IDENTIFIED IN PATIENTS WITH RETINITIS PIGMENTOSA.
Mutation cDNA Study population Diagnosis Reference
p.T373I* c.1118C>T Pakistan ARRP [18]
p.K663N c.1989G.>T U.S.A. ADRP [16]
p.A669T c.2005G>A Pakistan ARRP [18]
p.D984G c.2951A>G Chinese ADRP [21]
p.N985Y c.2954A>T Chinese ADRP [39]
p.K1370E c.4108A>G Chinese SRP Present Study
p.R1652L c.4955G>T Chinese SRP Present Study
p.L1808P c.5423T>C U.S.A. ADRP [16]
Asterisk represents homozygote.
Figure  3.  Summary  of  the  Retinitis
Pigmentosa 1 (RP1) mutation pattern in
patients  with  retinitis  pigmentosa
among  different  ethnic  populations.
Most  RP1  mutations  are  single
nucleotide  substitutions  producing  a
premature  stop  codon  or  insertion/
deletion changes resulting in a truncated
protein. Only a few missense variants
have been found to be disease causing.
So far only in Chinese missense variants
have  been  found  to  be  more  than
truncated mutations.
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